Overview
Applied DNA Sciences
Counterfeiters needn't apply here. Applied DNA Sciences makes anti-counterfeiting and product authentication solutions. Its products are encoded with botanical DNA sequences that can distinguish counterfeits from the genuine article. The DNA markers (which hold the SigNature DNA brand) can be employed in ink, glue, holograms, microchips, and paint, and are then used to tag documents, currency, event tickets, and clothing labels. The company applies
...
Read More its SigNature markers to art and collectibles, fine wine, consumer products, digital recording media, pharmaceuticals, and homeland security products.
Read Less
Read More its SigNature markers to art and collectibles, fine wine, consumer products, digital recording media, pharmaceuticals, and homeland security products.
Read Less
JUDITH MURRAH
See more contacts
Scientific Research and Development Services
,
Pharmaceutical and Medicine Manufacturing
,
Architectural, Engineering, and Related Services
,
Biotechnical research, commercial
,
Biological products, except diagnostic
See All Industries Testing laboratories
See Fewer Industries
See All Industries Testing laboratories
See Fewer Industries
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
?
Modelled
?
Actual
$3.43 million
Actual
-74.33%
$12
SEP
?
?
NASDAQ:APDN
Contacts
Get in Touch with 3 Principals* and 37 Contacts
-
JUDITH MURRAHChairman of the Board and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of September 30, 2024 (12 month period) in USD
Annual Revenue 2024
$3.43 million
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | -$14 | -$6 | -$9 |
| Net Investing Cash | -$0 | -$1 | -$0 |
| Net Financing Cash | $13 | $ | $18 |
| Net Change in Cash | -$1 | -$7 | $9 |
| Cash at Beginning of Period | $8 | $15 | $7 |
| Cash at End of Period | $7 | $8 | $15 |
| Capital Expenditure | -$0 | -$0 | -$0 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $6 | $7 | $15 |
| Accounts Receivable | $0 | $0 | $3 |
| Inventories | $0 | $0 | $1 |
| Other Current Assets | $1 | $0 | $1 |
| Asset Summary | |||
| Total Current Assets | $8 | $8 | $20 |
| Tangible Fixed Assets | $1 | $2 | $2 |
| Intangible Assets | $3 | $3 | $ |
| Total Assets | $13 | $14 | $22 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1 | $1 | $2 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $1 | $2 | $2 |
| Liability Summary | |||
| Total Current Liabilities | $2 | $3 | $4 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $4 | $9 | $9 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$310 | -$302 | -$293 |
| Equity Summary | |||
| Total Equity | $9 | $5 | $13 |
| Shares Outstanding | 206,237 | 13,658 | 12,908 |